| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 15727 |
| 1 | ADAPALENE | 14769 |
| 2 | ETANERCEPT | 12956 |
| 3 | AVOBENZONE, OCTISALATE, AND OCTOCRYLENE | 12512 |
| 4 | METHOTREXATE SODIUM | 11750 |
| 5 | PREDNISONE | 11040 |
| 6 | METHOTREXATE | 10588 |
| 7 | LENALIDOMIDE | 9068 |
| 8 | ASPIRIN | 7927 |
| 9 | ASPIRIN 81 MG | 7457 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | CETIRIZINE HYDROCHLORIDE, PSEUDOEPHEDRINE HYDROCHLORIDE | 136 | 0.6904 |
| 1 | GADOXETATE DISODIUM | 158 | 0.3892 |
| 2 | PSEUDOEPHEDRINE HCL | 864 | 0.2652 |
| 3 | CETIRIZINE HCL, PSEUDOEPHEDRINE HCL | 92 | 0.2599 |
| 4 | CORTISONE ACETATE | 1040 | 0.2498 |
| 5 | DESOXIMETASONE | 1369 | 0.2333 |
| 6 | ALPELISIB | 641 | 0.1938 |
| 7 | MOGAMULIZUMAB-KPKC | 89 | 0.1630 |
| 8 | ERLOTINIB HYDROCHLORIDE | 6157 | 0.1586 |
| 9 | GOLD | 527 | 0.1537 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 24533 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 24201 |
| 2 | Tumor Necrosis Factor Blocker [EPC] | 18314 |
| 3 | Retinoid [EPC] | 15742 |
| 4 | Anti-epileptic Agent [EPC] | 13231 |
| 5 | Platelet Aggregation Inhibitor [EPC] | 12690 |
| 6 | Kinase Inhibitor [EPC] | 12594 |
| 7 | Benzodiazepine [EPC] | 11078 |
| 8 | Folate Analog Metabolic Inhibitor [EPC] | 10532 |
| 9 | Thalidomide Analog [EPC] | 10207 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Chemokine Receptor Type 4 Interaction [EPC] | 89 | 0.1630 |
| 1 | Mucocutaneous Epithelial Cell Growth Factor [EPC] | 39 | 0.1068 |
| 2 | PCSK9 Inhibitor [EPC] | 1777 | 0.1027 |
| 3 | Lipoglycopeptide Antibacterial [EPC] | 69 | 0.0994 |
| 4 | CD4-directed Blocking Antibody [EPC] | 19 | 0.0974 |
| 5 | Interleukin-4 Receptor alpha Antagonist [EPC] | 6021 | 0.0972 |
| 6 | Interferon alpha [EPC] | 6163 | 0.0897 |
| 7 | Epidermal Growth Factor Receptor Antagonist [EPC] | 3033 | 0.0889 |
| 8 | Urease Inhibitor [EPC] | 4 | 0.0889 |
| 9 | Interleukin-6 Receptor Antagonist [EPC] | 6026 | 0.0873 |